A phase 1 clinical trial of a new cellular immunotherapy being developed in Australia for the treatment of multiple sclerosis (MS) has found that it improved symptoms and quality of life for the majority of patients. …
Latest Video
New Stories
-
CSL and CEPI agreement on COVID-19 vaccine for Australia
June 5, 2020 - - Latest News -
US 'Operation Warp Speed' selects priority vaccines
June 5, 2020 - - Latest News -
Three years on pathways, then along comes this
June 5, 2020 - - Latest News -
Federal government commits $300m to global vaccine alliance
June 5, 2020 - - Latest News -
BMS announces positive data for PBS-listed biologic
June 5, 2020 - - Latest News -
Pfizer Invites: ‘Life on the Other Side’
June 4, 2020 - - Latest News -
Maybe investigate the issue rather than just get rid of it?
June 4, 2020 - - Comment